BridgeBio Signals 3 Launches in Next 7 Months with BBP-418 Nov 27 PDUFA and Infigratinib Feb 4, 2027 PDUFA (NASDAQ:BBIO).
BridgeBio Signals 3 Launches in Next 7 Months with BBP-418 Nov 27 PDUFA and Infigratinib Feb 4, 2027 PDUFA (NASDAQ:BBIO).
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in